Loo, C, Glozier, N, Barton, D, Baune, BT, Mills, NT
, Fitzgerald, P, Glue, P, Sarma, S, Galvez-Ortiz, V, Hadzi-Pavlovic, D, Alonzo, A, Dong, V, Martin, D, Nikolin, S, Mitchell, PB, Berk, M, Carter, G, Hackett, M, Leyden, J, Hood, S, Somogyi, AA, Lapidus, K, Stratton, E, Gainsford, K, Garg, D, Thornton, NLR, Fourrier, C, Richardson, K, Rozakis, D, Scaria, A, Mihalopoulos, C, Chatterton, ML, McDonald, WM, Boyce, P, Holtzheimer, PE, Kozel, FA, Riva-Posse, P & Rodgers, A 2024, '
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial - CORRIGENDUM',
British Journal of Psychiatry, vol. 225, no. 2, pp. 349.
https://doi.org/10.1192/bjp.2024.189